Technology
Health
Biotechnology

Retrophin

$20.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.64 (-3.01%) Today
$0.00 (0.00%) As of 4:41 PM EDT after-hours

Why Robinhood?

You can buy or sell Retrophin and other stocks, options, ETFs, and crypto commission-free!

About RTRX

Retrophin, Inc. Common Stock, also called Retrophin, is a biopharmaceutical company. Read More It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.

Employees
214
Headquarters
San Diego, California
Founded
2008
Market Cap
880.56M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
373.04K
High Today
$21.38
Low Today
$20.49
Open Price
$21.33
Volume
556.37K
52 Week High
$33.00
52 Week Low
$17.53

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
US
North America

RTRX News

ReutersJul 18

'Pharma Bro' Martin Shkreli to stay behind bars, loses appeal of conviction

20

RTRX Earnings

-$0.68
-$0.43
-$0.18
$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 25, After Hours

More RTRX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.